Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic pens come in three strengths, and the 0.5 mg dose represents the most common starting point for GLP-1 receptor agonist therapy. Each pen holds enough medication for a complete month of weekly injections, with the total volume and dose count varying by pen strength. Knowing how many doses fit inside your pen helps you manage your injection schedule and track your medication supply.
Understanding Ozempic Pen Dose Capacity
An Ozempic pen labeled 0.5 mg contains a single 0.5 milligram dose per injection, not multiple smaller doses within one pen. The confusion often arises because patients receive multiple pens throughout their treatment course as they advance through dose escalation protocols. Each individual pen delivers one fixed injection amount, and the pen is then discarded after that single use.
Ozempic pens available in the United States come in three strengths: 0.25 mg, 0.5 mg, and 1 mg per injection. A patient starting on the standard titration schedule typically uses one 0.25 mg pen for four weeks, then moves to a 0.5 mg pen for four weeks, before potentially advancing to 1 mg. This stepped approach allows the body to acclimate to the medication while minimizing gastrointestinal side effects.
How Monthly Injection Schedules Work With Semaglutide
Semaglutide is administered as a once-weekly subcutaneous injection, meaning patients use one pen every seven days for approximately four weeks per month. Over the course of a full month, a patient typically needs four to five pens depending on the exact calendar alignment of their injection day. This weekly dosing schedule provides consistent GLP-1 receptor activation throughout the treatment cycle.
The standard semaglutide escalation pathway spans 16 weeks, during which patients progress through dose increases every four weeks to minimize adaptation and side effects. Starting at 0.25 mg, patients increase to 0.5 mg, then 1 mg, and finally to 2.4 mg as the maintenance dose for weight loss. Each dose level requires a different pen strength, so patients receive multiple prescriptions spaced across their first four months of therapy.
PlexusDx Compounded Semaglutide as an Alternative
PlexusDx offers compounded semaglutide injection from licensed 503A compounding pharmacies at a flat monthly rate of $149, eliminating flat per-compound pricing variability. Unlike brand-name Ozempic pens, compounded formulations allow for flexible dosing adjustments within a single vial, giving providers more precision in titration schedules. Patients access this medication across all 50 states without insurance requirements or membership fees.
The Precision Peptide Genetic Test available through PlexusDx identifies individual variations in GLP-1 receptor pathways, FTO metabolism, and MC4R signaling that influence treatment response. This genetic insight helps providers personalize semaglutide dosing and predict which patients may benefit from faster escalation or alternative compounds. At $99 as an add-on after the first month, this test optimizes therapy before significant dose progression.
Tracking Your Semaglutide Dose Schedule and Refills
Patients on semaglutide therapy should maintain a written or digital injection log noting the date, time, and dose of each weekly injection to ensure consistent administration. This record becomes essential when communicating with healthcare providers about side effects, appetite suppression timing, or the need for dose adjustments. Many patients photograph their pen count to track remaining doses and request refills at the appropriate time.
Supply management differs between brand Ozempic and compounded semaglutide: brand pens require separate prescriptions for each strength tier, while compounded formulations often arrive in a single vial with multiple doses inside. PlexusDx coordinates refills on a monthly cycle, ensuring patients never run low on medication while maintaining consistent weekly dosing. HSA and FSA accounts cover compounded semaglutide, making it accessible to patients with these tax-advantaged savings plans.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does one Ozempic pen contain multiple 0.5 mg doses, or just one?
One Ozempic 0.5 mg pen delivers a single 0.5 milligram dose per injection. Each pen is a one-time-use device that is discarded after injection. Throughout your treatment, you will use multiple pens as you progress through dose escalations over 16 weeks.
How many Ozempic pens do I need for one month of treatment?
Since semaglutide is injected once weekly, you typically need four to five pens per month depending on your injection day and calendar alignment. A standard month contains 28-31 days, which translates to four complete weeks of therapy.
What's the cost difference between brand Ozempic pens and PlexusDx compounded semaglutide?
PlexusDx compounded semaglutide injection costs a flat $149 per month regardless of dose strength, with no insurance required. This contrasts with brand-name Ozempic, which typically costs significantly more out-of-pocket or requires insurance coverage. PlexusDx doses may increase, but your price remains flat.
Can I adjust semaglutide doses within a single PlexusDx compounded vial?
Yes. Compounded semaglutide from licensed 503A pharmacies comes in multi-dose vials with flexible dosing, allowing providers to prescribe precise adjustments week-to-week without needing separate pen strengths. This flexibility supports faster or slower titration based on individual tolerance and genetic factors identified by the Precision Peptide Genetic Test.
How does the PlexusDx Precision Peptide Genetic Test help personalize my semaglutide dosing?
The Precision Peptide Genetic Test examines 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide. These results help your provider anticipate your optimal dose, predict side effect risk, and determine if dual-compound GLP-Squared therapy might work better for your genetics. At $99 added after your first month, it transforms guesswork into precision medicine.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Fast to Lose Weight on Ozempic: Understanding the Journey
What is the Lowest Dose of Semaglutide for Weight Loss?